This podcast series is an extension of IQVIA's continued support and thought leadership related to COVID-19 and its impact on the global pharmaceutical market. In this episode, IQVIA experts explore a new segment of patients that have emerged as a result of this pandemic.
Description: In this episode, Hannah Law, Head of U.S. Thought Leadership and Communications, shares how COVID-19 has shaped the way she embodies leadership and how she fosters her team. Hannah also details three pieces of advice she feels are important for the next generation of women in life sciences to keep in mind.
Featured Speaker: Hannah Law, Head of U.S. Thought Leadership and Communications
Description: Jimena Martinez, Associate Director Global Clinical Quality Management, discusses what inspires her and how she plans to personally call out gender bias and inequality in 2021. We also hear how her experience working in life sciences has changed her.
Featured Speaker: Jimena Martinez, Associate Director Global Clinical Quality Management at IQVIA
Description: Prithvi Addepalli, MHA, Consultant, Strategic Consulting, Patient Centered Solutions at IQVIA, shares the ways in which she plans to take on calling out gender bias and inequality in 2021. She also discusses how working with IQVIA has changed her, and her advice for the next generation of women in healthcare.
Featured Speaker: Prithvi Addepalli, MHA, Consultant, Strategic Consulting, Patient Centered Solutions at IQVIA
Description: Real World Evidence Site Manager, Chetana Khan, shares her experiences working with IQVIA and highlights some major wins she’s passionately worked towards achieving. Hear how she pulls inspiration from her daily life which acts as foundation for her professional life.
Featured Speaker: Chetana Khan, Real World Evidence Site Manager at IQVIA
Description: IQVIA’s Lisa Scibetta-Bruce, Manager in U.S. Marketing, discusses how her career has evolved and where she sees herself in the future. Listen as she gives advice to the next generation of women working in healthcare in terms of what they should or shouldn’t do to pursue leadership positions.
Featured Speaker: Lisa Scibetta-Bruce, Manager in U.S. Marketing
In this episode, we hear from Lisa Stockwell Morris, VP & GM of U.S. Real World Solutions at IQVIA, about her experience working with IQVIA and how the challenges she’s experienced have shaped her. We hear from Lisa how she would advise the next generation of women working in healthcare and the importance for personal and professional evolution.
Featured Speaker: Lisa Stockwell Morris, VP & GM of U.S. Real World Solutions at IQVIA
In this episode, we hear from Nandini Selvam, VP & GM of IQVIA Government Solutions, as she describes what has been some highlights in her career before and during her time with IQVIA. Hear how she expects the COVID-19 pandemic will shape the way the next generation of women in leadership go about creating change.
Featured Speaker: Nandini Selvam, VP & GM of IQVIA Government Solutions
The healthcare ecosystem has shown incredible resilience and an impressive appetite for adaption as we continue to live through the COVID-19 pandemic. This is especially true for clinical trials which have been maintained through innovation and the efforts of teams on the ground. Listen to hear the real-life experiences and strategy for managing a complex COVID-19 clinical trial from two of IQVIA's Clinical Project Managers.
Host: Ken Lee, Chief Medical Officer, IQVIA Asia Pacific
Feature Speakers: Cyril Vincent, Senior Clinical Project Manager, IQVIA Asia Pacific
Sarah Woodward, Clinical Project Manager, IQVIA Asia Pacific
In an era where every healthcare organization has a digital mandate, what does it take to be "digital forward thinking"? Listen to learn what it takes to implement a digital mandate and create true value for the end user.
Host: Ruthie Burr, Strategic Marketing Consultant, APAC
Featured Speaker: Swapna Kondapuram, Director, Regional HQ Clinical & Real World Evidence, IQVIA Consumer Health
Nicholas Mageras, Principal, Digital Strategy Lead, IQVIA Technologies
As virtual tools become more ingrained in our personal and professional lives, what will this mean for virtual Real World Evidence (RWE) in Consumer Health? Listen to learn about RWE, Consumer Insights in a self-care reality.
Host: Ruthie Burr, Strategic Marketing Consultant, APAC
Feature Speakers: Swapna Kondapuram, Director, Regional HQ Clinical & Real World Evidence, IQVIA Consumer Health
Dr. Pranab Kalita, Global medical affairs Respiratory & Skin Health, GSK Consumer Healthcare
What is Human Data Science? Listen for a Human Data Science 101 and learn why this familiar sounding term is essential to better understanding COVID-19 and preventing future disease outbreaks.
Host: Hannah Law, Head of Enterprise Content, IQVIA
Feature speaker: Murray Aitken, Executive Director, IQVIA Institute for Human Data Science
Welcome to the Human Data Scientist, a series about what we don't know in healthcare and how we can know more. Join us as we chat with industry leaders on how medicine and data science, when brought together in the right way, can achieve something remarkable.
Host: Hannah Law, Head of Enterprise Content, IQVIA
In the second episode of a two-part series, explore two low-impact scenarios for a post-COVID-19 world, Journey Disrupted and Reputation Reborn.
Journey Disrupted: Plans based on a coordinated national-level healthcare policy that would limit surges in COVID-19 infections and accelerate the reopening of non-urban areas in some states.
Reputation Reborn: Plans based on the idea that the virus would subside or be “under control” by mid-2021 due to effective disease management and therapies.
To explore the two high-impact scenarios, listen to Scenario planning for a post COVID-19 world (Ep. 1)
Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA
COVID-19 will have a lasting impact on U.S. business and care delivery models. In a two-episode series, explore four different scenarios for a post COVID-19 world. In the first of two episodes, learn about the exercise conducted to develop the four scenarios and explore the two high-impact scenarios, The Long Night and Too Many Moving Parts.
The Long Night: Plans for high impact in the U.S. that would continue beyond the next 18 months with no effective disease management before 2022.
Too Many Moving Parts: Plans based on the assumption that some COVID-19 impact continues for 18 months or more, but that management options exist for vulnerable or high-priority populations.
To explore the two low-impact scenarios, listen to Scenario planning for a post COVID-19 world (part 2)
Featured speaker: Mason Tenaglia, Vice President, Thought Leadership, IQVIA
